BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19155493)

  • 21. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathymic Deletion of IL-7 Reveals a Contribution of the Bone Marrow to Thymic Rebound Induced by Androgen Blockade.
    Rodrigues PM; Ribeiro AR; Serafini N; Meireles C; Di Santo JP; Alves NL
    J Immunol; 2018 Feb; 200(4):1389-1398. PubMed ID: 29321277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Flt3- and Ras-dependent pathway primes B cell development by inducing a state of IL-7 responsiveness.
    Li LX; Goetz CA; Katerndahl CD; Sakaguchi N; Farrar MA
    J Immunol; 2010 Feb; 184(4):1728-36. PubMed ID: 20065110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human thymic epithelial cells inhibit IL-15- and IL-2-driven differentiation of NK cells from the early human thymic progenitors.
    Le PT; Adams KL; Zaya N; Mathews HL; Storkus WJ; Ellis TM
    J Immunol; 2001 Feb; 166(4):2194-201. PubMed ID: 11160272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells.
    Lau-Kilby AW; Kretz CC; Pechhold S; Price JD; Dorta S; Ramos H; Trinchieri G; Tarbell KV
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2408-13. PubMed ID: 21262836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the earliest NK-cell precursor in the mouse BM.
    Carotta S; Pang SH; Nutt SL; Belz GT
    Blood; 2011 May; 117(20):5449-52. PubMed ID: 21422472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
    Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
    Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-15 is an essential mediator of peripheral NK-cell homeostasis.
    Ranson T; Vosshenrich CA; Corcuff E; Richard O; Müller W; Di Santo JP
    Blood; 2003 Jun; 101(12):4887-93. PubMed ID: 12586624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement for membrane lymphotoxin in natural killer cell development.
    Iizuka K; Chaplin DD; Wang Y; Wu Q; Pegg LE; Yokoyama WM; Fu YX
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6336-40. PubMed ID: 10339588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways.
    Luther C; Warner K; Takei F
    Blood; 2011 Apr; 117(15):4012-21. PubMed ID: 21355093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny.
    Wang B; Hollander GA; Nichogiannopoulou A; Simpson SJ; Orange JS; Gutierrez-Ramos JC; Burakoff SJ; Biron CA; Terhorst C
    Int Immunol; 1996 Jun; 8(6):939-49. PubMed ID: 8671683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flt3 ligand-receptor interaction is important for maintenance of early thymic progenitor numbers in steady-state thymopoiesis.
    Kenins L; Gill JW; Holländer GA; Wodnar-Filipowicz A
    Eur J Immunol; 2010 Jan; 40(1):81-90. PubMed ID: 19830725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells.
    Sandau MM; Schluns KS; Lefrancois L; Jameson SC
    J Immunol; 2004 Dec; 173(11):6537-41. PubMed ID: 15557143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors.
    Dolence JJ; Gwin K; Frank E; Medina KL
    Eur J Immunol; 2011 Feb; 41(2):324-34. PubMed ID: 21268003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.
    Mrózek E; Anderson P; Caligiuri MA
    Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors.
    Sitnicka E; Buza-Vidas N; Ahlenius H; Cilio CM; Gekas C; Nygren JM; Månsson R; Cheng M; Jensen CT; Svensson M; Leandersson K; Agace WW; Sigvardsson M; Jacobsen SE
    Blood; 2007 Oct; 110(8):2955-64. PubMed ID: 17540845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NK Cell Precursors in Human Bone Marrow in Health and Inflammation.
    Bozzano F; Perrone C; Moretta L; De Maria A
    Front Immunol; 2019; 10():2045. PubMed ID: 31555276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.
    Guerrero AD; Dong MB; Zhao Y; Lau-Kilby A; Tarbell KV
    Immunology; 2014 Dec; 143(4):640-50. PubMed ID: 24954893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection.
    Barber EM; Pollard JW
    J Immunol; 2003 Jul; 171(1):37-46. PubMed ID: 12816981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-7 enhances thymic human T cell development in "human immune system" Rag2-/-IL-2Rgammac-/- mice without affecting peripheral T cell homeostasis.
    van Lent AU; Dontje W; Nagasawa M; Siamari R; Bakker AQ; Pouw SM; Maijoor KA; Weijer K; Cornelissen JJ; Blom B; Di Santo JP; Spits H; Legrand N
    J Immunol; 2009 Dec; 183(12):7645-55. PubMed ID: 19923447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.